Anti-HER-2/neu antibodies detected in sera of patients with breast cancer, but also in healthy females [3]

European Journal of Cancer

Volumn 34, Issue 13, 1998, Pages 2135-

  Jasinska, J ^b   Wiltschke, C ^b   Brodowicz, T ^b   Zielinski, G G ^b   Hoffmann Sommergruber, K ^b   Zeillinger, R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEU DIFFERENTIATION FACTOR;

ANTIBODY TITER; BREAST CANCER; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; LETTER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; RECEPTOR, ERBB-2;

EID: 0032402443     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00221-4     Document Type: Letter

References (1)

1. 1. Disis ML, Pupa SM, Gralow JR, Dittadi R, Menard S, Cheever MA. High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer. J Clin Oncol 1997, 15, 3363-3367.